Alyeska Investment Group
AZN icon

Alyeska Investment Group’s AstraZeneca AZN Stock Holding History

Alyeska Investment Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,062,278
Closed -$210M – 667
2026
Q1 		$210M Buy
1,062,278
+198,880
+23% +$38.3M 0.59% 32
2025
Q4 		$159M Buy
863,398
+592,315
+218% +$104M 0.45% 48
2025
Q3 		$41.6M Buy
271,083
+14,427
+6% +$2.18M 0.13% 195
2025
Q2 		$35.9M Sell
256,656
-195,844
-43% -$27.4M 0.13% 201
2025
Q1 		$66.5M Sell
452,500
-1,061,256
-70% -$154M 0.27% 106
2024
Q4 		$198M Buy
1,513,756
+1,041,823
+221% +$146M 0.75% 20
2024
Q3 		$73.5M Sell
471,933
-737,515
-61% -$119M 0.38% 91
2024
Q2 		$189M Sell
1,209,448
-188,393
-13% -$28.3M 1.08% 16
2024
Q1 		$189M Buy
1,397,841
+1,110,342
+386% +$147M 1.17% 8
2023
Q4 		$38.7M Sell
287,499
-413,429
-59% -$53.7M 0.26% 124
2023
Q3 		$94.9M Buy
+700,928
New +$95.7M 0.64% 38
2020
Q3 		– Sell
-11,419
Closed -$1.21M – 466
2020
Q2 		$1.21M Buy
+11,419
New +$1.18M 0.02% 390
2018
Q4 		– Sell
-13,143
Closed -$1.04M – 367
2018
Q3 		$1.04M Buy
+13,143
New +$994K 0.01% 346
2018
Q1 		– Sell
-1,178,615
Closed -$81.8M – 446
2017
Q4 		$81.8M Buy
+1,178,615
New +$79.5M 0.65% 51

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Alyeska Investment Group's AZN Position: Q2 2026 in Review

Alyeska Investment Group sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1,062,278 shares — an estimated $210M sold.

Alyeska Investment Group first reported a position in AZN in Q4 2017 and held it in 14 quarters. The position peaked at $210M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Alyeska Investment Group reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 1,062,278 AstraZeneca shares in Q2 2026, an estimated $210M.
  • Alyeska Investment Group first reported a position in AstraZeneca in Q4 2017 and held it in 14 quarters.
  • Alyeska Investment Group's AstraZeneca position peaked at $210M in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.